Finance

Lists
237690:KOSDAQ
ST Pharm Co Ltd
â‚©91,000.00
-1.83%
(-1,700.00) 1D
Sep 21, 3:30:11 PM GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 237690...
Open
â‚©93,000
High
â‚©93,300
Low
â‚©90,400
Mkt. cap
1.90T
Avg. vol.
174.43K
Volume
60.23K
Dividend
0.55%
Quarterly dividend
â‚©125
Ex-dividend date
Mar 30, 2026
P/E ratio
25.12
52-wk high
â‚©172,100
52-wk low
â‚©84,100
EPS
â‚©3,622
Shares outstanding
20.88M
No. of employees
655
Open
â‚©93,000
High
â‚©93,300
Low
â‚©90,400
Mkt. cap
1.90T
Avg. vol.
174.43K
Volume
60.23K
Dividend
0.55%
Quarterly dividend
â‚©125
Ex-dividend date
Mar 30, 2026
P/E ratio
25.12
52-wk high
â‚©172,100
52-wk low
â‚©84,100
EPS
â‚©3,622
Shares outstanding
20.88M
No. of employees
655
About ST Pharm Co Ltd
CEOSung Moo-je
Employees655
Founded1983
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in KRW
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in KRW
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
81.91B
129.10B
66.96B
108.48B
Cost of goods sold
45.91B
82.18B
36.89B
70.01B
Cost of revenue
45.91B
82.18B
36.89B
70.01B
Research and development expenses
6.68B
5.41B
6.51B
7.30B
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
13.44B
12.75B
10.73B
11.74B
Operating expense
21.27B
20.66B
18.54B
20.17B
Total operating expenses
67.19B
102.84B
55.43B
90.18B
Operating income
14.72B
26.26B
11.53B
18.31B
Other non operating income
6.25B
-614.92M
6.14B
-171.41M
EBT including unusual items
20.98B
29.28B
17.67B
18.14B
EBT excluding unusual items
20.98B
22.67B
17.67B
18.14B
Income tax expense
3.52B
-1.75B
2.47B
4.98B
Effective tax rate
16.76%
-5.97%
13.96%
27.49%
Other operating expenses
182.89M
249.13M
189.97M
230.72M
Net income
17.57B
30.95B
15.06B
13.21B
Net profit margin
21.45%
23.97%
22.50%
12.18%
Earnings per share
-
-
-
-
Interest and investment income
-
3.45B
-
-
Interest expense
-
-4.04B
-
-
Net interest expenses
-
-583.18M
-
-
Depreciation and amortization charges
695.46M
512.37M
667.07M
628.42M
EBITDA
23.11B
34.57B
20.05B
26.88B
Gain or loss from assets sale
-5.70M
308.18M
279.00K
-380.00K
AI content may include mistakes. Learn more
Google apps